Vantage mHealthcare Inc. – a leading mobile health technology company – is developing point-of-care screening using Apps based upon chemical sensing residing within a small Bluetooth device that works with any smartphone, tablet or laptop.
With its foundations in advanced nanotechnology, the company’s first product, the Vantage Sensor, is the convergence of nano-electronics, bio-informatics, and wireless technology. The first FDA Approved mobile App is expected to be for lung cancer screening. The first application not requiring FDA approval is expected to be for marijuana screening for law enforcement. Additional mobile Apps are in the planning stages.

You can find out helpful information from the National Institute of Health or the National Cancer Institute or the American Cancer Society.